Zhongshan Ophthalmic Center, State Key Laboratory of Ophthalmology, Sun Yat-sen University, Guangzhou, China.
Proteomics Clin Appl. 2007 Sep;1(9):972-82. doi: 10.1002/prca.200700125. Epub 2007 Aug 10.
Human tear fluid is charactered with very small volume and complex protein constitutes with a very large orders of magnitude. The tear proteome analysis provides a unique dataset (i.e., specific protein markers or protein patterns) that may be correlated to more effective diagnosis, prognosis, and response to therapy. Compared to less than 100 tear proteins obtained by the traditional methods, more than 400 proteins have been found in human tear fluid by current proteomic technologies. Many proteomics techniques, such as 2-DE, MALDI-TOF-MS, LC-MS, SELDI-TOF-MS, protein arrays, have been used to perform tear proteome analysis in healthy and/or disease subjects. The clinical application of tear proteomics needs suitable tear collection methods, standard tear handling procedures, and more sensitive and reliable proteomic technologies.
人眼泪液的特点是体积非常小,蛋白质组成非常复杂,数量级很大。泪液蛋白质组分析提供了一个独特的数据集(即特定的蛋白质标记物或蛋白质模式),可能与更有效的诊断、预后和治疗反应相关。与传统方法获得的不到 100 种泪液蛋白相比,目前的蛋白质组学技术已经在人泪液中发现了 400 多种蛋白质。许多蛋白质组学技术,如 2-DE、MALDI-TOF-MS、LC-MS、SELDI-TOF-MS、蛋白质芯片,已被用于对健康和/或疾病受试者进行泪液蛋白质组分析。泪液蛋白质组学的临床应用需要合适的泪液采集方法、标准的泪液处理程序以及更敏感和可靠的蛋白质组学技术。